0000950123-23-010967.txt : 20231114 0000950123-23-010967.hdr.sgml : 20231114 20231114163846 ACCESSION NUMBER: 0000950123-23-010967 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231114 DATE AS OF CHANGE: 20231114 EFFECTIVENESS DATE: 20231114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MPM BioImpact LLC CENTRAL INDEX KEY: 0001687078 IRS NUMBER: 364818254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-20107 FILM NUMBER: 231407245 BUSINESS ADDRESS: STREET 1: 399 BOYLSTON STREET, SUITE 1100 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6174259200 MAIL ADDRESS: STREET 1: 399 BOYLSTON STREET, SUITE 1100 CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: BioImpact Capital LLC DATE OF NAME CHANGE: 20210831 FORMER COMPANY: FORMER CONFORMED NAME: MPM Oncology Impact Management LP DATE OF NAME CHANGE: 20161007 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE 0001687078 XXXXXXXX 09-30-2023 09-30-2023 false MPM BIOIMPACT LLC

399 BOYLSTON STREET, SUITE 1100 BOSTON MA 02116

13F HOLDINGS REPORT 028-20107 000309865 801-119133 N Brendan Furey (617) 425-9222 /s/Brendan Furey Boston MA 11-13-2023 0 32 374602543 false INFORMATION TABLE 2 28212.xml INFORMATION TABLE FOR FORM 13F Adaptimmune Therapeutics plc Sponsored ADR 00653A107 3974811 5095912 SH SOLE 5095912 0 0 Amicus Therapeutics Inc. Common 03152W109 8708250 716139 SH SOLE 716139 0 0 Avadel Pharmaceuticals PLC Common 05337M104 6841507 664224 SH SOLE 664224 0 0 Axsome Therapeutics, Inc. Common 05464T104 6540726 93586 SH SOLE 93586 0 0 Crinetics Pharmaceuticals Inc. Common 22663K107 14247036 479053 SH SOLE 479053 0 0 Cullinan Oncology, Inc. Common 230031106 69216825 7648268 SH SOLE 7648268 0 0 CYMABAY THERAPEUTICS INC Common 23257D103 9106581 610770 SH SOLE 610770 0 0 Geron Corporation Common 374163103 22710460 10712481 SH SOLE 10712481 0 0 Harpoon Therapeutics, Inc. Common 41358P205 1288270 319670 SH SOLE 319670 0 0 Inozyme Pharma Inc. Common 45790W108 1373068 326921 SH SOLE 326921 0 0 Insmed Incorporated Common 457669307 13318315 527458 SH SOLE 527458 0 0 Kalvista Pharmaceuticals Inc Common 483497103 5565736 577958 SH SOLE 577958 0 0 Karuna Therapeutics Inc Common 48576A100 8997279 53210 SH SOLE 53210 0 0 Intellia Therapeutics, Inc. Common 45826J105 17221485 544639 SH SOLE 544639 0 0 Iovance Biotherapeutics Inc Common 462260100 14957656 3287397 SH SOLE 3287397 0 0 iTeos Therapeutics, Inc. Common 46565G104 19118076 1745943 SH SOLE 1745943 0 0 Madrigal Pharmaceuticals inc Common 558868105 5967048 40859 SH SOLE 40859 0 0 Moonlake Immunotherapeutics Common 61559X104 16768830 294190 SH SOLE 294190 0 0 MORPHIC HOLDING INC Common 61775R105 4582000 200000 SH SOLE 200000 0 0 Olema Pharmaceuticals, Inc. Common 68062P106 22942360 1857681 SH SOLE 1857681 0 0 Phathom Pharmaceuticals inc Common 71722W107 3601833 347332 SH SOLE 347332 0 0 REGENXBIO Inc. Common 75901B107 10809578 656718 SH SOLE 656718 0 0 Relay Therapeutics Inc. Common 75943R102 11371439 1352133 SH SOLE 1352133 0 0 Repare Therapeutics, Inc. Common 760273102 19809376 1639849 SH SOLE 1639849 0 0 Revolution Medicines, Inc. Common 76155X100 7567933 273408 SH SOLE 273408 0 0 STRUCTURE THERAPEUTICS INC Common 86366E106 11634970 230761 SH SOLE 230761 0 0 Travere Therapeutics Inc. Common 89422G107 4942443 552846 SH SOLE 552846 0 0 Verve Therapeutics, Inc Common 92539P101 11376284 857940 SH SOLE 857940 0 0 VIKING THERAPEUTICS INC Common 92686J106 3597750 325000 SH SOLE 325000 0 0 Viridian Therapeutics Inc Common 92790C104 3916655 255323 SH SOLE 255323 0 0 Xeris Biopharma Holdings Inc Common 98422E103 7417619 3987967 SH SOLE 3987967 0 0 Werewolf Therapeutics, Inc. Common 95075A107 5110344 2388011 SH SOLE 2388011 0 0